CUTR Cutera Inc.

Cutera Announces Global Commercial Launch Of the excel V+® the Next Generation Laser Platform

Cutera Announces Global Commercial Launch Of the excel V+® the Next Generation Laser Platform

Developed in Collaboration with Leading Dermatologists, For Indications in Vascular, Skin and Pigmentation Treatments

WASHINGTON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- On the eve of the 2019 American Academy of Dermatology (AAD) Annual Conference, Cutera, Inc. (Nasdaq:CUTR), (“Cutera” or the “Company”), announces the launch of its best-in-class excel V+ laser platform.  The excel V+ is a technological advancement that includes 50% more power and treatment speed, optimized delivery systems and parameters for unparalleled precision in treating vascular lesions and pigmentation concerns.

The excel V+ represents a significant leap forward in the Company’s current excel V laser platform, widely recognized among dermatologists for its engineering excellence as a best-in-class platform for the treatment of dermatologic issues such as rosacea, poikiloderma, leg veins, skin pigmentation and acne scars. The advancements of the excel V+ include:

  • Fully-integrated 532/+ 1064 nm wavelengths, with the addition of ‘Green Genesis’ a micro-pulsed 532 nm procedure
  • 50% more power with the 532 nm wavelength
  • Large spot sizes up to 16 mm for 2X faster treatments
  • New ‘Dermastat’ tracing handpiece to quickly treat small vascular and pigmented lesions on the face and body

Dr. E. Vic Ross, world-renowned dermatologist practicing at Scripps Clinic, San Diego, CA stated, “I am very pleased to have collaborated with Cutera’s R&D team on the development of the excel V+.  The technological advancements of the new laser enhance an already best-in-class platform. The new capabilities will transform the experience of my patients. The advancement of the technology means I will be able to treat veins and vascular lesions and skin pigmentation more efficiently, precisely, and with improved results.” 

Market data demonstrates a large demand for these vascular and pigmentation treatments:

  • 415M people suffer from rosacea1
  • 84% of the population have spider veins2
  • 40% of the population suffer from pigment concerns3
  • Skin rejuvenation ranks in the top 10 of non surgical aesthetic procedures4

"The American Acadamy of Dermatologist is the largest and most influential dermatology group in the US, and we are thrilled to once again choose the AAD’s annual meeting to unveil the latest Cutera innovation.  The launch of the excel V+ marks another milestone for Cutera's goals in providing best-in-class aesthetics technology for providers worldwide. We are proud to be at the forefront of these innovations over the past twenty years, and will continue to develop clinical advancements in laser and light-based technology that provide the best in patient care,” said Jason Richey, COO and Interim CEO of Cutera.

Cutera will also be conducting live demonstrations of its extremely popular body sculpting device, truSculpt iD at AAD.  The Company will also host twelve leading dermatologists in their AAD booth #1501, who will share valuable insights on the latest trends in aesthetics treatments and technology. 

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit .

  1. Rosacea.org
  2. ASAPS 2017 Statistics

Cutera, Inc.

Tanya Rodante

Director, Marketing Communications

415-657-5500

EN
26/02/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cutera Inc.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: August 30, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Cutera Inc: 2 directors

Two Directors at Cutera Inc bought 35,000 shares at between 9.800USD and 9.910USD. The significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

BAH, HURN, NOTV, PAGS, SPOK, ROKU, BZH, HOV, MTH, SKX, SAM, DESP, BJRI, RKLB, IONQ, KLAC, INTC, CNX, CLB, CRK, OVV, SOFI, TROW, AX, CINF, DLR, ABR, RWT, BFST, INBK, AUPH, BBIO, DSGN, RPHM, URGN, RCEL, AXNX, CUTR, PLSE, In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patte...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch